T, T., R, T., R, T., S, U., H, K., Y, S., & S, F. (2021). Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: A cohort study. Clinical and experimental nephrology, 25(11), 1215. https://doi.org/10.1007/s10157-021-02094-9
Chicago Style (17th ed.) CitationT, Toida, Toida R, Takahashi R, Uezono S, Komatsu H, Sato Y, and Fujimoto S. "Impact of Polypharmacy on All-cause Mortality and Hospitalization in Incident Hemodialysis Patients: A Cohort Study." Clinical and Experimental Nephrology 25, no. 11 (2021): 1215. https://doi.org/10.1007/s10157-021-02094-9.
MLA (9th ed.) CitationT, Toida, et al. "Impact of Polypharmacy on All-cause Mortality and Hospitalization in Incident Hemodialysis Patients: A Cohort Study." Clinical and Experimental Nephrology, vol. 25, no. 11, 2021, p. 1215, https://doi.org/10.1007/s10157-021-02094-9.